Morgan Stanley stuft St Jude Medical von equal weight auf overweight.
(© BörseGo AG 2012 - Autor: Tobias Krieg, Redakteur)
| 34,176 Euro | +0,036 +0,11 % | ||
| WKN: 864096 ISIN: US7908491035 Ticker-Symbol: JUD | Frankfurt | 19.06.13 | 08:03 Uhr |
Branche GesundheitswesenAktienmarkt S&P 500 |
|
|
Morgan Stanley stuft St Jude Medical von equal weight auf overweight.
| Zeit | Aktuelle Nachrichten | |
|---|---|---|
| 11.06. | St. Jude Medical Gets FDA Approval For Ellipse And SJM Assura Family Of Devices | |
| WASHINGTON (dpa-AFX) - Medical device maker St. Jude Medical, Inc. (STJ)
said Tuesday that the U.S. Food and Drug Administration has approved the
company's next-generation Ellipse and SJM... Mehr lesen zu: St. Jude Medical Gets FDA Approval For Ellipse And SJM Assura Family Of Devices | ||
| 11.06. | St. Jude Medical (STJ) Next-Gen Ellipse and SJM Assura Approved by FDA | |
Mehr lesen zu: St. Jude Medical (STJ) Next-Gen Ellipse and SJM Assura Approved by FDA | ||
| 10.06. | St. Jude Medical schließt Beteiligungsvertrag mit Übernahmeoption mit Spinal Modulation | |
| Vereinbarung sichert St. Jude Medical sofortige internationale Vertriebsrechte für das Neurostimulatorsystem Axium und eine längerfristige Exklusivoption zur Übernahme des Unternehmens ... Mehr lesen zu: St. Jude Medical schließt Beteiligungsvertrag mit Übernahmeoption mit Spinal Modulation | ||
| 10.06. | New Studies, Regulatory Submissions, and Leadership Changes - Research Report on St. Jude Medical, Teva Pharmaceutical Industries, Avanir Pharmaceuticals, Novo Nordisk, and Trius Therapeutics | |
| NEW YORK, June 10, 2013 /PRNewswire/ --
Editor Note: For more information about this release, please scroll to bottom.
Today, Wall Street Reports announced new research reports highlighting St.... Mehr lesen zu: New Studies, Regulatory Submissions, and Leadership Changes - Research Report on St. Jude Medical, Teva Pharmaceutical Industries, Avanir Pharmaceuticals, Novo Nordisk, and Trius Therapeutics | ||
| 09.06. | St. Jude Medical Boosts Anti-Pain Portfolio In $40M Deal | |
Mehr lesen zu: St. Jude Medical Boosts Anti-Pain Portfolio In $40M Deal |